...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >OXA-244-Producing Escherichia coli Isolates, a Challenge for Clinical Microbiology Laboratories
【24h】

OXA-244-Producing Escherichia coli Isolates, a Challenge for Clinical Microbiology Laboratories

机译:牛-244-生产大肠杆菌分离株,临床微生物学实验室的挑战

获取原文
获取原文并翻译 | 示例

摘要

OXA-244 is a single-point-mutant derivative of OXA-48 displaying reduced carbapenemase activity. Here, we report the microbiological features of seven OXA-244-producing Escherichia coli isolates. Only one isolate grew on ChromID Carba Smart medium (bioMerieux), but six of the seven isolates grew on ChromID extended-spectrum-beta-lactamase (ESBL) medium (bioMerieux), as they coproduced an ESBL and/or a plasmid-encoded cephalosporinase. The production of a carbapenemase was detected in 57.1%, 71.4%, 71.4%, and 100% of the E. coli isolates using the Carba NP test, the Rapidec Carba NP test (bioMerieux), a matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) hydrolysis assay (Bruker), and the OXA-48 K-SeT assay (Coris BioConcept), respectively. Our results indicate that OXA-244-producing E. coli isolates are difficult to detect, which may lead to their silent spread.
机译:Oxa-244是氧气-48的单点突变衍生物,显示出降低的碳结构酶活性。 在这里,我们报告了七种氧气-244产生的大肠杆菌分离株的微生物特征。 只有一个孤立在铬Carba智能介质(Biomerieux)上增长,但是七个分离物中的六个分离物在染色体扩展光谱 - β-内酰胺酶(ESBL)培养基(BioMerieux)上增长,因为它们携带ESBL和/或质粒编码的头孢菌素酶 。 使用Carba NP测试,Rapidec Carba NP试验(BioMerieux),MATRIX辅助激光解吸电离 - 时间以57.1%,71.4%,71.4%和100%的大肠杆菌分离株检测到碳丙二糖酶的生产。 飞行质谱(MALDI-TOF MS)水解测定(BRUKER)和OXA-48 k设定测定(Coris Bioconcept)。 我们的结果表明,生产大肠杆菌分离物的氧气-244难以检测,这可能导致其沉默的扩散。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号